In a matched analysis involving 110 patients with transformed indolent non-Hodgkin lymphoma (TriNHL) and 391 patients with de novo large B-cell lymphoma (LBCL), CAR T-cell therapy showed superior ...
AYA lymphoma patients often experience delayed diagnosis due to transitional life stages and lack of primary care or insurance. Lymphoma types and presentations in AYAs differ from those in children ...
Lymphoma is the third most common cancer in US children, with Hodgkin and non-Hodgkin types affecting them differently. Common symptoms include swollen lymph nodes, fever, and fatigue, with diagnosis ...
What Is Marginal Zone Lymphoma? Marginal zone lymphoma (MZL) isn’t one disease. It’s a group of rare, slow-growing blood cancers. They’re known as non-Hodgkin lymphomas because they start in your ...
A next-generation, anti-CD19 enhanced CAR T-cell therapy that secretes interleukin-18 achieved a response in 81% of lymphoma patients who failed previous CAR T-cell therapy. Duration of response was 9 ...
Stage 2 lymphoma is localized, affecting lymph nodes or a single extranodal site on one diaphragm side, with a favorable prognosis. Diagnosis involves biopsies, blood tests, and imaging to confirm ...
Stage 4 lymphoma is a cancer of white blood cells called lymphocytes that has spread outside the lymph nodes to other parts of the body. While this is an advanced stage, treatment options are ...
Persistent itching can sometimes signal serious illness, including cancer. Oncologist Dr Amit Garg highlights four ...
Hodgkin’s lymphoma is a type of cancer that can affect children and adolescents. Some research suggests that the Epstein-Barr virus may increase the risk of Hodgkin’s lymphoma. Chemotherapy and ...